Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease. World J Gastroenterol 2011;17(9):1095-108.
. Personalized therapies in pediatric inflammatory and autoimmune diseases. Curr Pharm Des 2012;18(35):5766-75.
. Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?. World J Gastroenterol 2014;20(13):3534-41.
. TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. Pharmacogenomics 2014;15(5):619-27.
. Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome. Pharmacogenomics 2015;16(14):1631-48.
. Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children. Int J Mol Sci 2015;16(8):18601-27.
. Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives. Curr Med Chem 2017;24(11):1050-1065.
. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis 2017;23(4):628-634.
. Pharmacogenetics of treatments for inflammatory bowel disease. Expert Opin Drug Metab Toxicol 2018;14(12):1209-1223.
.